Viewing Study NCT02040857


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-01-01 @ 10:05 AM
Study NCT ID: NCT02040857
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2014-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: